Zafirlukast is a prescription medication used for the long-term management of asthma. It belongs to a class of drugs called leukotriene receptor antagonists (LTRAs). These medications help reduce airway inflammation and prevent asthma symptoms. Zafirlukast is not a rescue inhaler and does not provide immediate relief during an asthma attack. Instead, it is taken daily to help prevent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Although the brand name Accolate® has been discontinued in the United States, generic zafirlukast remains available.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Zafirlukast is a prescription medication used for the long-term management of asthma. It belongs to a class of drugs called leukotriene receptor antagonists (LTRAs). These medications help reduce airway inflammation and prevent asthma symptoms. Zafirlukast is not a rescue inhaler and does not provide immediate relief during an asthma attack. Instead, it is taken daily to help prevent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Although the brand name Accolate has been discontinued in the United States, generic zafirlukast remains available.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
Provider review within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Important safety information
Zafirlukast is generally well-tolerated; however, certain conditions warrant caution or avoidance of this medication. Recognizing these contraindications ensures patients receive the safest and most effective treatment.
Understanding absolute contraindications helps healthcare providers identify patients who may need alternative therapies. These should be closely evaluated for other asthma treatments that don’t carry the same risks.
Recognizing these contraindications and precautions ensures that Zafirlukast is used safely and effectively, minimizing potential risks while maximizing therapeutic benefits in asthma management. Working closely with healthcare providers to monitor health changes and adjust treatment as necessary is essential. This proactive approach to managing asthma with Zafirlukast enhances patient safety and treatment effectiveness.
Albuterol is a prescription bronchodilator that helps open the airways in the lungs. Albuterol is used to prevent and treat bronchospasm in people with asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders. It works quickly by relaxing the muscles around the airways, often providing relief within minutes during asthma attacks or episodes of sudden shortness of breath. It is available by prescription only in several forms, including metered-dose inhalers (such as ProAir HFA), nebulizer solutions (such as AccuNeb), and tablets.
Budesonide is a prescription corticosteroid used as a daily maintenance treatment to prevent and control asthma symptoms in adults and children. By reducing airway inflammation and swelling, it improves breathing and helps prevent asthma attacks. It is available as a dry powder inhaler and as a nebulizer suspension for those who have difficulty using inhalers. Budesonide must be used consistently as prescribed, even when symptoms are absent. After each use, rinse your mouth with water to help prevent oral thrush, a common side effect.
Symbicort is a prescription combination inhaler used to manage asthma and chronic obstructive pulmonary disease (COPD). It contains a corticosteroid to reduce airway inflammation and a long-acting bronchodilator to relax airway muscles, improving breathing. Used daily as maintenance therapy, Symbicort helps prevent asthma attacks and COPD flare-ups but is not intended for sudden breathing issues. It must be used exactly as prescribed and not for acute shortness of breath—use a rescue inhaler instead. Rinse your mouth with water after each use to help prevent oral thrush.
Fluticasone propionate is a corticosteroid nasal spray used to treat nasal congestion, sneezing, and a runny or itchy nose caused by seasonal, perennial, or nonallergic rhinitis. It works by reducing inflammation in the nasal passages to relieve allergy symptoms at their source. While not a decongestant, consistent daily use typically controls symptoms within several days.
Fluticasone propionate is the generic version of Flovent HFA and Flovent Diskus, an inhaled corticosteroid used every day to prevent asthma symptoms in adults and children 4 years and older. It calms inflammation in the airways so they are less sensitive, less swollen, and less likely to tighten up. We carry the Prasco authorized generic in both the HFA metered-dose inhaler (44, 110, and 220 mcg) and the Diskus dry powder inhaler (50, 100, and 250 mcg). It is a maintenance medicine, not a rescue inhaler, and is available by prescription only.
Fluticasone propionate and Salmeterol is a prescription inhaler used to manage asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It combines a corticosteroid to reduce airway inflammation and a long-acting beta₂-agonist (LABA) to relax airway muscles, helping to prevent wheezing, coughing, and shortness of breath. It is taken regularly, usually twice daily, for long-term symptom control and is not a rescue inhaler.
Zafirlukast is a leukotriene receptor antagonist (LTRA). Primarily used to manage and treat asthma, Zafirlukast helps alleviate symptoms by reducing airway inflammation. Its action is crucial for patients with chronic asthma, as it helps prevent asthma attacks and improve overall respiratory function. Zafirlukast stands as a generic alternative to the branded drug Accolate, offering an economical option for individuals requiring long-term asthma management.
In the landscape of asthma treatments, Zafirlukast distinguishes itself by its unique mechanism: it directly interacts with leukotriene receptors, which are part of the inflammatory cascade in asthma. This impact not only helps reduce asthma symptoms but also helps keep the airways clear by mitigating factors such as bronchoconstriction and excess mucus production. As a result, Zafirlukast plays a vital role in the comprehensive treatment plan for asthma by maintaining steady airway function and enhancing the quality of life for those who suffer from this condition.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Accolate was the original brand-name version of zafirlukast. It was approved by the U.S. Food and Drug Administration (FDA) in 1996 for the chronic treatment of asthma. While the brand-name product Accolate® has been discontinued in the United States, generic zafirlukast remains available and provides the same active ingredient and therapeutic effect. Patients prescribed Accolate today typically receive the generic form, zafirlukast, unless their healthcare provider specifies otherwise.
Zafirlukast has specific applications in the treatment and management of asthma and other airway conditions. It serves both as a preventive treatment and as a supportive medication for ongoing asthma management.
While primarily known for its role in asthma management, Zafirlukast also finds application in treating other conditions due to its anti-inflammatory properties.
The versatility of Zafirlukast in addressing these conditions highlights its importance in respiratory care. By functioning as a preventive agent, it reduces the need for rescue treatments and supports better management of chronic inflammatory respiratory disorders. Its role in the therapeutic landscape provides patients with more options to tailor their asthma management to better suit their individual needs.
Zafirlukast plays a crucial role in asthma management by targeting the inflammatory pathway associated with leukotrienes. Understanding its mechanism of action and pharmacokinetics provides insight into how it effectively manages respiratory conditions.
Zafirlukast binds to and blocks leukotriene receptors in the airway walls. Leukotrienes are potent chemicals produced during inflammatory responses that contribute to airway constriction, heightened mucus production, and overall inflammation. By inhibiting the interaction between leukotrienes and their receptors, Zafirlukast reduces bronchoconstriction and mucus production.
This allows the bronchial muscles to relax, improving airway opening and overall breathing function. The blocking of these receptors is pivotal in controlling the chronic inflammatory process that characterizes asthma.
Upon oral administration, Zafirlukast is well absorbed, reaching peak plasma concentrations within 1 to 3 hours. Its bioavailability is susceptible to interference from food, which can reduce absorption, underscoring the importance of taking the medication on an empty stomach for optimal efficacy.
Following absorption, Zafirlukast is extensively metabolized in the liver. It is predominantly excreted through feces, with a half-life of approximately 10 hours, making it sufficiently long-acting to support twice-daily dosing regimens. The pharmacokinetic profile of Zafirlukast supports its application as a reliable long-term treatment option in chronic asthma care.
Through its mechanism of action and pharmacokinetic properties, Zafirlukast offers sustained relief for asthma sufferers, and patients are advised to adhere to prescribed dosing schedules to maintain consistent therapeutic levels in the body. This therapeutic consistency facilitates better asthma control, reducing both the frequency and severity of asthma symptoms and attacks.
Understanding the correct dosages and administration guidelines for Zafirlukast is crucial for its effectiveness in managing asthma. Proper use ensures that the medication can efficiently reduce inflammation and prevent asthma symptoms.
The prescribed dosage must be strictly followed to ensure optimal control of asthma symptoms. Adjustments should only be made under professional medical guidance.
Zafirlukast should be taken on an empty stomach to optimize its absorption. Specifically, it should be consumed either 1 hour before meals or 2 hours after meals. Maintaining consistent dosing intervals enhances the drug’s efficacy by maintaining stable blood levels. The medication is available as an oral tablet, and adherence to a regular dosing schedule is encouraged to achieve the best outcomes in terms of symptom control and reduction of asthma attacks.
If a dose is missed, it should be taken as soon as remembered. However, if it’s nearly time for the next scheduled dose, skip the missed dose to avoid doubling up. Regular adherence to the dosing schedule is key to maintaining therapeutic effectiveness.
In the event of an overdose, immediate medical attention is required. Symptoms such as headache, drowsiness, or gastrointestinal discomfort may occur, necessitating prompt evaluation by healthcare professionals to manage any adverse effects and prevent complications.
By following these guidelines, patients can ensure they use Zafirlukast effectively for asthma management. Consistency and adherence to prescribed dosing regimens play a crucial role in the successful control of asthma symptoms and overall management of the condition.
While Zafirlukast is generally well-tolerated, as with any medication, it may cause side effects. These can range from common and mild to serious and warrant attention from healthcare providers.
These common side effects are typically mild and often diminish as treatment continues. However, if they persist or cause significant discomfort, consulting with a healthcare provider is advisable.
Pregnant women should use Zafirlukast only if the benefits justify the potential risks. Consulting a healthcare provider is essential before starting the medication during pregnancy. The occurrence of any serious side effects necessitates stopping the medication and seeking medical attention promptly, as early intervention can prevent further complications. Understanding potential risks helps patients use Zafirlukast safely and effectively as part of their asthma management plan.
Zafirlukast can interact with other medications, affecting its efficacy and safety. Awareness of these interactions is key to optimizing treatment and preventing adverse effects.
Being vigilant about potential drug interactions ensures the safe and effective use of Zafirlukast. Patients should always inform their physicians of all the medications they take, including over-the-counter drugs and supplements, to manage potential interactions.
Awareness and management of these interactions contribute to a safer and more effective asthma treatment plan. Engaging with healthcare providers to tailor therapy and monitor potential interactions can optimize Zafirlukast use while minimizing associated risks.
Administration & Dosage
Zafirlukast should be taken by mouth, usually twice daily on an empty stomach. This means taking the medication one hour before or two hours after meals to ensure optimal absorption and effectiveness. Follow your healthcare provider's instructions carefully, and refer to the medication guide for specific details relevant to your treatment plan.
The typical dosage for adults prescribed Zafirlukast is 20 mg taken twice daily. However, it's crucial to follow the dosage recommendations provided by your healthcare provider, as they may adjust the dosage based on your individual medical condition and response to the treatment.
Zafirlukast can be prescribed to children aged 5 years and older. The usual dosage for children in this age group is 10 mg taken twice daily. Ensure any pediatric use of Zafirlukast is under the supervision of a healthcare provider who can monitor the child's response and adjust the dosage if necessary.
Zafirlukast is available as a tablet for oral administration. This form provides a convenient way for patients to manage asthma symptoms through a consistent medication regimen. Always store the tablets in their original container, away from light and moisture, to maintain their efficacy.
If a dose is missed, take it as soon as you remember. If it's almost time for the next scheduled dose, skip the missed dose and continue with the regular dosing schedule. Avoid taking an extra dose to compensate for the one missed, as this can lead to potential overdose or increased side effects.
Uses & Mechanism of Action
Zafirlukast, marketed under the brand name Accolate, is primarily used to manage and prevent asthma symptoms. It achieves this by reducing inflammation and preventing the narrowing of the airways, easing breathing, and reducing the occurrence of asthma attacks.
Zafirlukast functions by blocking leukotriene receptors. Leukotrienes are molecules in the body that contribute to inflammation, swelling, and lung constriction associated with asthma. By hindering these receptors, Zafirlukast helps to control asthma symptoms and improve respiratory function over time.
Zafirlukast is considered a long-acting medication. It does not provide immediate relief for acute asthma attacks but is designed to offer continuous management of asthma symptoms when taken regularly. This sustained action helps maintain stable lung function and reduce the frequency of asthma exacerbations.
The primary therapeutic benefit of Zafirlukast is the reduction in asthma symptoms, such as wheezing, coughing, and shortness of breath. Regular use can also decrease the frequency of asthma attacks, improve overall lung function, and enhance the quality of life for patients dealing with chronic asthma.
Zafirlukast is a prescription medication, meaning it should only be used with a healthcare provider's consent and guidance. The provider will assess the patient’s specific condition and determine if Zafirlukast is an appropriate choice for their asthma management plan, including necessary dosage adjustments and monitoring.
Side Effects & Safety
Common side effects of Zafirlukast include headaches, nausea, diarrhea, and a sore throat. These effects are generally mild and resolve as the body adjusts to the medication. If these symptoms persist or worsen, it's advisable to contact a healthcare provider for further evaluation and support.
More serious side effects of Zafirlukast can include signs of liver dysfunction, such as persistent nausea, unusual tiredness, or yellowing of the skin/eyes (jaundice). Additionally, mood alterations or an increased risk of infections may occur. Immediate medical attention is recommended if any serious symptoms manifest.
Pregnant women should consult their healthcare provider before taking Zafirlukast. The medication should be used during pregnancy only if the potential benefits justify the potential risk to the fetus. Your doctor will help determine whether Zafirlukast is suitable for use during your pregnancy.
Zafirlukast is deemed safe for children aged 5 years and older, but should be prescribed and monitored by a healthcare professional. Careful attention will be given to the child’s response to therapy, and the dosage may need to be adjusted based on therapeutic outcomes and any side effects.
Before starting Zafirlukast, inform your doctor of your full medical history, especially any liver disease or mental health conditions. Perform activities requiring mental alertness with caution if you experience dizziness or drowsiness. Regular liver function tests may be suggested to monitor safety.
Interactions & Contraindications
Caution is advised when taking Zafirlukast alongside other medications, as it can interact with medications like warfarin or certain seizure drugs. Always inform your healthcare provider about all prescriptions, over-the-counter products, or supplements you are taking to prevent any adverse interactions.
Alcohol consumption should be limited while taking Zafirlukast. Alcohol may exacerbate the risk of liver damage, a significant concern with Zafirlukast therapy. Discuss your alcohol use with your healthcare provider to ensure it's safe in combination with your prescribed medications.
Zafirlukast is contraindicated in individuals who have a known hypersensitivity to the drug or its ingredients. If an allergic reaction occurs, characterized by symptoms such as rash, itching, swelling, or severe dizziness, seek immediate medical intervention appropriate for treating allergic manifestations.
No specific dietary restrictions are associated with Zafirlukast. However, it is important to take the medication on an empty stomach, 1 hour before or 2 hours after meals, to optimize absorption and ensure the drug's efficacy in managing asthma symptoms.
In the event of an overdose of Zafirlukast, it's critical to seek emergency medical attention. Symptoms may include headache, drowsiness, or gastrointestinal disturbances. Prompt treatment can help mitigate potential complications and support recovery from overdose effects.
Generic & Alternatives
Zafirlukast is the generic version of the brand Accolate. The generic version provides the same pharmacological effects and therapeutic benefits as the branded form, often at a lower cost, making it a suitable option for patients seeking cost-effective asthma management.
Alternative asthma medications include other leukotriene receptor antagonists, such as Montelukast. Additionally, inhaled corticosteroids and bronchodilators may be considered, depending on individual patient needs and asthma severity. Consultation with a healthcare provider can help determine the best alternative treatment.
There is currently no indication that Zafirlukast is being discontinued globally. However, its availability may fluctuate based on regional pharmaceutical decisions. Patients should confirm availability with their provider or pharmacist to ensure consistent access to their prescribed treatment.
Substitution of Zafirlukast with another medication should be done only under the guidance of a healthcare provider. Risk/benefit evaluation by your provider ensures any substitute maintains asthma management and aligns with your individual health profile and therapeutic needs.
While both Zafirlukast and Montelukast are leukotriene receptor antagonists used primarily for asthma management, they are different medications. They have distinct dosing regimens and therapeutic profiles. A healthcare provider can guide which medication best suits your health requirements.